Beyond the Healthline summary of the UK Biobank-derived Nature study, the observational data (n≈500,000, no randomization) reveals a U-shaped curve where deviations outside 6.4–7.8 hours correlate with accelerated epigenetic and proteomic aging signatures across 17 organs. What coverage missed is the study's reliance on self-reported sleep without objective actigraphy validation, potentially inflating effect sizes amid unmeasured confounders like shift work or socioeconomic status; prior smaller cohorts (e.g., 2022 JAMA Network Open analysis of 8,000 adults) showed similar brain-specific acceleration but lacked organ-specific clocks. Cross-referencing with a 2023 Nature Aging paper on inflammation pathways indicates short sleep elevates IL-6 and CRP, impairing tissue repair—mechanisms the original report underplays—while excessive sleep may proxy subclinical disease rather than cause aging. No conflicts of interest were declared in the primary work, yet the clocks' machine-learning training on the same Biobank cohort risks circularity. These patterns position sleep duration as a high-leverage, modifiable longevity lever when integrated with circadian and metabolic data.